Global Oral Anti-Diabetic Drug Market to Acquire USD 47.2 BN By 2025

Posted On October 14, 2019

Value Market Research has added a new report on the Global Oral Anti-Diabetic Drug Market which was valued USD 24.2 BN (by revenue) in 2018 and is anticipated to reach USD 47.2 BN by 2025 with a CAGR of 10% from 2019 to 2025. The rising incidence of diabetes across the globe is expected to raise the demand for oral anti-diabetic drugs. The growth of this market can also be accredited to the ongoing advancement in terms of technologies and drugs coupled with the favorable reimbursement medicines policies. Moreover, the rising number of the pharmaceutical industry and the growing development of novel and new therapy is further anticipated to propel the market growth.

Anti-diabetic drugs are those medicines which are used to treat diabetes mellitus (type 2) which is the most common type of diabetes. People with diabetes 2 have insulin resistance condition. This medicine works by lowering the glucose level in the blood and the medicines which can be consumed orally are called oral anti-diabetic drugs. The oral anti-diabetic drugs increases the insulin secretion level by improving the pancreatic ß-cell functioning.

The report "Global Oral Anti-Diabetic Drug Market Report By Product (Sulfonylureas, Biguanides, Alpha-Glucosidase Inhibitors, Megalitinides And Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation, And Forecast, 2018-2025" pin points the growth areas, enabling a better profit making decision. The analysis is much focused involving high data accuracy.

The market segmentation included in the report are by product and region. Product segment encompasses Sulfonylureas, biguanides, alpha-glucosidase inhibitors, megalitinides, and others. Sulfonylureas held the leading position as they are commonly used oral anti-diabetic drug as they work by increasing the insulin release from the beta cells in the pancreas. Regional segmentation covers North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is dominating the overall market owing to the presence of strong government favorable policies for oral anti-diabetes drugs in the region. 
 
The Report Segments Global Oral Anti-Diabetic Drug Market -
By Product

  • Sulfonylureas

    • Glimepiride

    • Gliclazide

    • Glyburide

    • Others

  • Biguanides

    • Metformin

    • Others

  • Alpha-Glucosidase Inhibitors

    • Acarbose

    • Voglibose

    • Others

  • Megalitinides

    • Repaglinide

    • Netaglinide

  • Others

By Region

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Companies Profiled -
Abbott, AstraZeneca, Biocon, Eli Lilly and Company, Merck & Co., Inc., Novartis AG, Novo Nordisk A/S, Pfizer Inc., Sanofi and Sun Pharmaceutical Industries

Download the FREE SAMPLE of Global Oral Anti-Diabetic Drug Market Research Report

 
About Value Market Research -
Value Market Research was established with the vision to ease decision making and empower the strategists by providing them with holistic market information. Our analysts’ team is well equipped with all research tools and techniques and hold deep knowledge of the industry they are working for.

We ensure intellectual, precise and quality data is delivered to our client. We facilitate clients with syndicate research reports and customized research reports on 25+ industries with global as well as regional coverage.

Contact:
Value Market Research
401/402, TFM, Nagras Road, Aundh, Pune-7.
Maharashtra, INDIA.
Tel: +1-888-294-1147
Email: [email protected]
Website: https://www.valuemarketresearch.com

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Clients

Testimonials